Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1991 Sep;32(5):315–324. doi: 10.1007/BF01789050

Hypotension and disseminated intravascular coagulation following intralesional bacillus Calmette-Guérin therapy for locally metastatic melanoma

Max H Cohen 1,2,3,✉, Ronald J Elin 4, Barry J Cohen 5,6
PMCID: PMC11037993  PMID: 1998973

Abstract

Four patients developed serious hypotension and signs of disseminated intravascular coagulation shortly after a second round of Tice bacillus Calmette-Guérin (BCG) injections into locally recurrent cutaneous melanoma satellite nodules. Each of these patients survived following intensive therapy with isoniazid, pyridoxine, steroids, pressors, antibiotics, and cardio-renal support including, in one case, three acute hemodialyses. Plasma specimens from two of the four patients caused gelation of lysate from the amebocytes ofLimulus polyphemus, indicating the presence of endotoxin or an endotoxin-like substance. In vitro studies on the BCG preparations led us to conclude that this endotoxin activity in the plasma is not the result of direct injection of endotoxin with the BCG preparation, but rather from release of endotoxin from endogenous sources, such as the intestinal tract during a period of relative hypotension following an allergic reaction. Prior immunity appeared to be the consistent factor in the toxic reactions reported herein. Finally, we present recommendations for serial monitoring of these patients and discuss the use of an alternative agent for intralesional therapy.

Keywords: Melanoma, Isoniazid, Pyridoxine, Metastatic Melanoma, Cutaneous Melanoma

References

  • 1.Briggs PC, Heckler F. Axillary lymphadenopathy: complication of BCG immunotherapy for melanoma. Plast Reconstr Surg. 1988;81:952–953. [PubMed] [Google Scholar]
  • 2.Clark WH, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanoma of the skin. Cancer Res. 1969;29:705–726. [PubMed] [Google Scholar]
  • 3.Clark WH, Ainsworth AM, Bernardino EA, Yang CH, Mihm MC. The developmental biology of primary human malignant melanomas. Semin Oncol. 1975;2:83–103. [PubMed] [Google Scholar]
  • 4.Caridis DT, Reinhold RB, Woodruff PWH, Fine J. Endotoxaemia in man. Lancet. 1972;1:1381–1386. doi: 10.1016/s0140-6736(72)91108-7. [DOI] [PubMed] [Google Scholar]
  • 5.Cohen SG, Benaceraf B, McClusky RT, Ovary Z. Effect of anticoagulants on delayed hypersensitivity reactions. J Immunol. 1967;98:351. [PubMed] [Google Scholar]
  • 6.Cohen MH, Jessup JM, Felix EL, Weese JL, Herberman RB. Intralesional treatment of recurrent cutaneous malignant melanoma. Cancer. 1978;41:2456–2463. doi: 10.1002/1097-0142(197806)41:6<2456::aid-cncr2820410654>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  • 7.Colvin RB, Dvorak HH. Role of the clotting system in cellmediated hypersensitivity: II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions. J Immunol. 1975;144:377. [PubMed] [Google Scholar]
  • 8.Colvin RB, Johnson RA, Mihm MC., Jr Role of the clotting system in cell-mediated hypersensitivity: I. Fibrin deposition in delayed skin reaction in man. J Exp Med. 1973;138:686. doi: 10.1084/jem.138.3.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Cuevas P, Fine J. Demonstration of a lethal endotoxemia in experimental occlusion of the superior mesenteric artery. Surg Gynecol Obstet. 1971;133:81–83. [PubMed] [Google Scholar]
  • 10.Cuevas P, Fine J. Production of fatal endotoxic shock by vasoactive substances. Gastroenterology. 1973;64:285–291. [PubMed] [Google Scholar]
  • 11.Diamond J. Allergic reaction to BCG. Lancet. 1968;2:875. doi: 10.1016/s0140-6736(68)91038-6. [DOI] [PubMed] [Google Scholar]
  • 12.Elin RJ, Wolff SM. Biology of endotoxin. Annu Rev Med. 1976;27:127–141. doi: 10.1146/annurev.me.27.020176.001015. [DOI] [PubMed] [Google Scholar]
  • 13.Elin RJ, Robinson RA, Levine AS, Wolff SM. Lack of clinical usefulness of the limulus test in the diagnosis of endotoxemia. N Engl J Med. 1975;293:521–524. doi: 10.1056/NEJM197509112931102. [DOI] [PubMed] [Google Scholar]
  • 14.Fossard DP, Kakkar VV. The limulus test in experimental and clinical endotoxaemia. Br J Surg. 1974;61:798–804. doi: 10.1002/bjs.1800611013. [DOI] [PubMed] [Google Scholar]
  • 15.Flippin T, Mukheji B, Yogeshwar D. Granulomatous hepatitis as a late complication of BCG immunotherapy. Cancer. 1980;46:1759–1762. doi: 10.1002/1097-0142(19801015)46:8<1759::aid-cncr2820460810>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  • 16.Gans H, Matsumoto K. Are enteric endotoxins able to escape from the intestine? Proc Soc Exp Biol Med. 1974;147:736–739. doi: 10.3181/00379727-147-38428. [DOI] [PubMed] [Google Scholar]
  • 17.Grey HM, Briggs W, Farr RS. The passive transfer of sensitivity to antigen induced fever. J Clin Invest. 1961;40:703. doi: 10.1172/JCI104303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hamer-Hodges D, Woodruff P, Cuevas P, Kaufman A, Fine J. Role of the intraintestinal gram-negative bacterial flora in response to major injury. Surg Gynecol Obstet. 1973;138:599–603. [PubMed] [Google Scholar]
  • 19.Hochstein HD, Elin RJ, Cooper JF, Seligman EB, Jr, Wolff SM. Further developments of limulus amebocyte lysate test. Bull Parenter Drug Assoc. 1973;27:139–148. [PubMed] [Google Scholar]
  • 20.Israel-Biet D, Sandrun D, Chretien J. Pulmonary complications of intravesical bacille Calmette-Guérin immunotherapy. Am Rev Respir Dis. 1987;135:763–765. doi: 10.1164/arrd.1987.135.3.763. [DOI] [PubMed] [Google Scholar]
  • 21.Karpatkin S. Biochemical and clinical aspects of megathrombocytes. Ann NY Acad Sci. 1972;201:262–279. doi: 10.1111/j.1749-6632.1972.tb16304.x. [DOI] [PubMed] [Google Scholar]
  • 22.McKhann CF, Hendrickson CG, Spitler LE, Gunnarsson A, Banerjee D, Nelson WR. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection. Cancer. 1975;35:514–520. doi: 10.1002/1097-0142(197502)35:2<514::aid-cncr2820350233>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  • 23.Minna JD, Robboy SJ, Colman RW. Disseminated intravascular coagulation in man. Ill.: Thomas; 1974. pp. 19–25. [Google Scholar]
  • 24.de la Monte S, Hutchins G, et al. Fatal disseminated bacillus Calmette-Guérin infection and arrested growth of cutaneous malignant melanoma following intralesional immunotherapy. Dematopathol. 1986;8:331–335. doi: 10.1097/00000372-198608000-00010. [DOI] [PubMed] [Google Scholar]
  • 25.Morton DL, Eilber FR, Malmgren RA, Wood WC. Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery. 1970;68:158–164. [PubMed] [Google Scholar]
  • 26.Morton DL, Eilber FR, Holmes EC, Hunt JS, Ketcham AS, Silverstein MJ, Sparks FC. BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg. 1974;180:635–643. doi: 10.1097/00000658-197410000-00029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mott PD, Wolff SM. The association of fever and antibody response in rabbits immunized with human serum albumin. J Clin Invest. 1966;45:372. doi: 10.1172/JCI105352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Nathanson L. Regression of intradermal malignant melanoma after mycobacterium bovis strain BCG. Cancer Chemother Rep. 1972;56:659–665. [PubMed] [Google Scholar]
  • 29.Nelson DS. The effects of anticoagulants and other drugs on cellular and cutaneous reactions to antigen in guinea pigs with delayed-type hypersensitivity. Immunology. 1965;9:219. [PMC free article] [PubMed] [Google Scholar]
  • 30.Pareti FI, Capitarius A, Mennucci PM. Acquired storage pool disease in platelets during disseminated intravascular coagulation. Blood. 1976;48:511–515. [PubMed] [Google Scholar]
  • 31.Pinsky CM, Hirshaut Y, Oettgen HF. Treatment of malignant melanoma by intratumoral injection of BCG. Nat Cancer Inst Monogr. 1973;39:225–228. [PubMed] [Google Scholar]
  • 32.Root RK, Wolff SM. Pathogenic mechanisms in experimental immune fever. J Exp Med. 1968;128:309–323. doi: 10.1084/jem.128.2.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Salvin SB, Youngner JS, Lederer WH. Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. Infec Immun. 1973;7:68. doi: 10.1128/iai.7.1.68-75.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sparks FC. Hazards and complications of BCG immunotherapy. Med Clin N Am. 1976;60:499–509. doi: 10.1016/s0025-7125(16)31894-6. [DOI] [PubMed] [Google Scholar]
  • 35.Sparks FC, Silverstein MJ, Hunt JS, Haskell CM, Pilch YH, Morton DL. Complications of BCG immunotherapy in patients with cancer. N Engl J Med. 1973;289:827–830. doi: 10.1056/NEJM197310182891603. [DOI] [PubMed] [Google Scholar]
  • 36.Sparks FC, Highton A, Hunt JS, Scholnick PL. Generalized cutaneous reaction associated with the intratumor injection of BCG. Chest. 1975;68:725–727. [Google Scholar]
  • 37.Stein JA, Siltzki-Ciechanover M, Gefel A, Adler A, Michaeli D. Untoward fatal hemorrhagic diathesis in a BCG-treated melanoma patient. Cancer Immunol Immunother. 1978;4:269–270. [Google Scholar]
  • 38.Tamakuma S, Rogas-Corona R, Cuevas P, Fine J. Demonstration of a lethal endotoxemia of intestinal origin in refractory non-septic shock. Ann Surg. 1971;173:219–224. doi: 10.1097/00000658-197102000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wilson GS, Miles A. Principles of bacteriology, virology, and immunity. Baltimore: Williams and Wilkins; 1975. p. 574. [Google Scholar]
  • 40.Wolff SM. Biological effects of bacterial endotoxins in man. J Infect Dis [Suppl] 1973;128:251–256. doi: 10.1093/infdis/128.supplement_1.s259. [DOI] [PubMed] [Google Scholar]
  • 41.Woods JM, IV, Schellack J, Stewart MT, Murray DR, Schwartzman SW. Mycotic abdominal aortic aneurysm induced by immunotherapy with bacille Calmette-Guérin vaccine for malignancy. J Vasc Surg. 1988;7:807–810. doi: 10.1067/mva.1988.avs0070808. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES